Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP).

× No keyword cloud information.

65 in total

1. Correction of postkidney transplant anemia reduces progression of allograft nephropathy.

Authors: Gabriel Choukroun; Nassim Kamar; Bertrand Dussol; Isabelle Etienne; Elisabeth Cassuto-Viguier; Olivier Toupance; François Glowacki; Bruno Moulin; Yvon Lebranchu; Guy Touchard; Maïté Jaureguy; Nicolas Pallet; Yannick Le Meur; Lionel Rostaing; Frank Martinez
Journal: J Am Soc Nephrol Date: 2011-12-22 Impact factor: 10.121

2. Naturally occurring higher hemoglobin concentration does not increase mortality among hemodialysis patients.

Authors: David A Goodkin; Douglas S Fuller; Bruce M Robinson; Christian Combe; Richard Fluck; David Mendelssohn; Tadao Akizawa; Ronald L Pisoni; Friedrich K Port
Journal: J Am Soc Nephrol Date: 2010-12-16 Impact factor: 10.121

Review 3. Short-acting erythropoiesis-stimulating agents for anaemia in predialysis patients.

Authors: Deirdre Hahn; Christopher I Esezobor; Noha Elserafy; Angela C Webster; Elisabeth M Hodson
Journal: Cochrane Database Syst Rev Date: 2017-01-09

4. Beneficial dose conversion after switching from higher doses of shorter-acting erythropoiesis-stimulating agents to C.E.R.A in CKD patients in clinical practice: MINERVA Study.

Authors: Aleix Cases; José Portolés; Jordi Calls; Alberto Martinez-Castelao; María Antonia Munar; Alfonso Segarra
Journal: Int Urol Nephrol Date: 2014-08-14 Impact factor: 2.370

5. Darbepoetin alfa once every 2 weeks effectively maintained hemoglobin in dialysis patients in an observational study: Austrian cohort of ALTERNATE.

Authors: Wolfgang Pronai; Ulrich Neyer; Ursula Barnas; Clemens Wieser; Christine Jaeger; Daniel Dekic; Margit Hemetsberger; Alexander R Rosenkranz
Journal: Wien Med Wochenschr Date: 2014-01-31

6. Monthly administration of a continuous erythropoietin receptor activator provides efficient haemoglobin control in non-dialysis patients during routine clinical practice: results from the non-interventional, single-cohort, multicentre, SUPRA study.

Authors: Stefan Heidenreich; Frank Leistikow; Stefan Zinn; Jörg Baumann; Andreas Atzeni; Vitomir Bajeski; Jörn Dietzmann; Gert-Peter Dragoun
Journal: Clin Drug Investig Date: 2012-02-01 Impact factor: 2.859

7. Evaluation of the impact of a new synthetic vitamin E-bonded membrane on anemia and rHuEPO requirement in ESRD patients with central venous catheters: a pilot study.

Authors: S Mandolfo; B Corradi; R Bucci; M Farina; F Pilolli; F Galli
Journal: Int Urol Nephrol Date: 2011-09-29 Impact factor: 2.370

Review 8. Use of agents stimulating erythropoiesis in digestive diseases.

Authors: Rosario Moreno López; Beatriz Sicilia Aladrén; Fernando Gomollón García
Journal: World J Gastroenterol Date: 2009-10-07 Impact factor: 5.742

Review 9. Differentiating factors between erythropoiesis-stimulating agents: an update to selection for anaemia of chronic kidney disease.

Authors: Walter H Hörl
Journal: Drugs Date: 2013-02 Impact factor: 9.546

10. Trace elements in end-stage renal disease--unfamiliar territory to be revealed.

Authors: Adrian Covic; Paul Gusbeth-Tatomir
Journal: BMC Nephrol Date: 2009-06-02 Impact factor: 2.388